Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2015 | 08-2014 | 06-2014 | 08-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,353 | 2 | 2,640 | 2 | 2 |
| Receivables | 157 | N/A | N/A | N/A | 0 |
| Inventories | 39 | N/A | N/A | N/A | 0 |
| Income taxes - deferred | N/A | N/A | 19 | N/A | 0 |
| TOTAL | $8,042 | $3 | $3,302 | $2 | $2 |
| Non-Current Assets | |||||
| PPE Net | 30 | 3 | 57 | 8 | 8 |
| Intangibles | 2,273 | 0 | 700 | 0 | 0 |
| Other Non-Current Assets | 7,840 | 0 | 7,957 | 0 | 0 |
| TOTAL | $10,143 | $3 | $8,714 | $8 | $8 |
| Total Assets | $18,185 | $6 | $12,016 | $10 | $10 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,195 | 31 | 1,257 | 106 | 106 |
| Accrued Expenses | 197 | 19 | 150 | 14 | 14 |
| TOTAL | $1,478 | $51 | $6,092 | $121 | $121 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 86 | N/A | 86 | N/A | 0 |
| Other Non-Current Liabilities | 665 | 0 | 0 | 0 | 0 |
| TOTAL | $1,091 | $N/A | $554 | $N/A | $0 |
| Total Liabilities | $2,569 | $51 | $6,647 | $121 | $121 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,260 | 5,835 | N/A | 4,917 | N/A |
| Common Shares | 0 | 540 | 1 | 414 | 414 |
| Retained earnings | -18,381 | -630 | -10,658 | -569 | -569 |
| Other shareholders' equity | -5,000 | 0 | 0 | 3 | 3 |
| TOTAL | $15,617 | $-45 | $5,369 | $-111 | $-111 |
| Total Liabilities And Equity | $18,185 | $6 | $12,016 | $10 | $10 |